Ce document numérisé est le fruit d'un long travail approuvé par le ...

67. Dietrich, W. F., E. Lander, J. Smith, A Moser, K. Gould, C. Luongo, N. Borenstein, and W.
Dove. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal
neoplasia in the mouse. Cel! 75: 631-639, 1993.
68. Djouadi, F., C. J. Weinheimer, J. E. Saffitz, C. Pitchford, J. Bastin, F. J. Gonzalez, and D. P.
Kelly. A gender-related defect in Iipid metabolism and glucose homeostasis in peroxisome proliferatoractivated
receptor alpha- deficient mice. J Clin Invest 15: 1083-1091, 1998.
69. Dowell, P., J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy, and M. Leid. Identification of
nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein.
J Biol Chem 274: 15901-15907, 1999.
70. Dowell, P., J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy, and M. Leid. p300 functions
as a coactivator for the peroxisome proliferator-activated receptor alpha. J Biol Chem 272: 33435­
33443, 1997.
71. Dowell, P., V. J. Peterson, T. M. Zabriskie, and M. Leid. Ligand-induced peroxisome
proliferator-activated receptor alpha conformational change. J Biol Chem 272: 2013-2020, 1997.
72. Dreyer, C., H. Keller, A Mahfoudi, V. Laudet, G. Krey, and W. Wahli. Positive regulation of the
peroxisomal p-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated
receptors (PPAR). Biol. Cel! 77: 67-76, 1993.
73. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. Control of the
peroxisomal p-oxidation pathway by a novel family of nuclear hormone receptors. Cel! 68: 879-887,
1992.
74. Drummond, F., J. Sowden, K. Morrison, and Y. Edwards. The caudal-type homeobox protein
Cdx-2 binds to the colon promoter of the carbonic anhydrase 1 gene. Eur J Biochem 236: 670-681,
1996.
75. DuBois, R. N., R. Gupta, J. Brockman, B. S. Reddy, S. L. Krakow, and M. A. Lazar. The
nuclear eicosanoid receptors, PPARgamma, is aberrantly expressed in colonie cancers.
Carcinogenesis 19: 49-53, 1998.
76. Duprey, P., K. Chowdury, G. dressler, R. Balling, L. Simon, J. Guenet, and P. Gruss. A mouse
gene homologous to the Drosophilia gene Caudal is expressed in epithelial cells in the embryonic
intestine. Genes Dev2: 1647-1654, 1988.
77. Eastmann, Q., and R. Grosschedl. Regulation of LEFrrCF transcription factors by Wnt and
other signais. Curr Opin Cel! Biol 11 : 233-240, 1999.
78. Eastwood, G. Gastrointestinal epithelial renewal. Gastroenterology72: 962-,1977.
79. Eberhart, C., R. Coffey, A. Radhika, F. Giardiello, S. Ferrenbach, and R. Dubois. Up-regulation
of cyclooxygenase 2 gene in human colorectal adenomas and adenocarcinomas. Gastroenterology
107: 1183-1188, 1994.
80. Elbrecht, A, Y. Chen, C. Cullinan, N. Hayes, M. Leibowitz, D. Moller, and J. Berger. Molecular
cloning, expression and characterization of human peroxisome proliferator-activated receptors y1 and
12. Biochem Biophys Res Commun 224: 431-437,1996.
81. Ellis, C. N., J. Varani, G. J. Fisher, M. E. Zeigler, H. A. Pershadsingh, S. C. Benson, Y. Chi,
and T. W. Kurtz. Troglitazone improves psoriasis and normalizes models of proliferative skin disease :
ligands for peroxisome proliferator-activated receptor-y inhibit keratinocyte proliferation. Arch Dermatol
136: 609-616, 2000.
82. Eistner, E., C. Muller, K. Koshizuka, E. A. Williamson, D. Park, H. Asou, P. Shintaku, J. W.
Said, D. Heber, and H. P. Koeffler. Ligands for peroxisome proliferator-activated receptor-y and
retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in
BNX mice. Proc Nat! Acad Sci USA 95: 8806-8811, 1998.
83. Fajas, L., D. Auboeuf, E. Raspe, K. Schoonjans, A. M. Lefebvre, R. Saladin, J. Najib, M.
Laville, J. C. Fruchart, S. Deeb, A. Vidal Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, and J. Auwerx.
The organization, promoter analysis, and expression of the human PPAR gamma gene. J Biol Chem
272: 18779-18789, 1997.
84. Fajas, L., J. C. Fruchart, and J. Auwerx. PPARgamma3 mRNA : a distinct PPARgamma
mRNA subtype transcribed from an independent promoter. FEBS Letters 438: 55_60, 1998.
85. Fang, F" G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. Dependence of Cyclin E-CDK
2 kinase activity in cell anchorage. Science 271 : 499-502, 1996.
86. Febbraio, M., E. Podrez, J. Smith, D. Hajjar, S. Hazen, H. Hoff, K. Sharma, and R. Silverstein.
Targeted disruption of the c1ass B scavenger receptor CD36 protects against atherosclerotic lesion
development in mice. J Clin Invest 105: 1049-1056, 2000.
87. Feinberg, A. P., and B. Voigeistein. A technique for radiolabeling DNA restriction
endonuclease fragments to high specifie activity. Anal. Biochem. 132: 6-13, 1983.
114